Researchers Develop Nanoparticles to Reverse Alzheimer's in Mice, Offering New Hope for Treatment
An international team of researchers has achieved a significant breakthrough in Alzheimer's research by using specially engineered nanoparticles to reverse the disease in mice. These nanoparticles, developed by scientists from the Institute for Bioengineering of Catalonia and West China Hospital Sichuan University, act as drugs themselves, helping to restore the brain's natural cleaning system and reduce toxic protein buildup. The study, published in Signal Transduction and Targeted Therapy, focuses on repairing the blood-brain barrier, which deteriorates in Alzheimer's patients, allowing harmful proteins to accumulate. The nanoparticles, termed 'supramolecular drugs,' help restore this barrier and enhance the brain's waste removal capabilities. In tests, mice treated with these nanoparticles showed a significant reduction in amyloid-beta levels, a protein associated with Alzheimer's, within hours of treatment.